Central Drugs Standard Control Organization (CDSCO) Overview

The Central Drugs Standard Control Organization (CDSCO), under the Ministry of Health and Family Welfare, is India's National Regulatory Authority (NRA). Its medical device division is responsible for enforcing the Medical Device Rules, 2017 (MDR 2017) to ensure the safety, quality, and efficacy of medical devices and in vitro diagnostics (IVDs).

1. Risk-Based Classification

Medical devices in India are classified into four categories based on their intended use and risk level:

• Class A (Low Risk): Thermometers, stethoscopes, bandages.
• Class B (Low-Moderate Risk): Hypodermic needles, blood pressure monitors, surgical gloves.
• Class C (Moderate-High Risk): Ventilators, bone fixation implants, anesthesia machines.
• Class D (High Risk): Cardiac pacemakers, heart valves, coronary stents.

2. Licensing and Authorities

• Central Licensing Authority (CLA): Headed by the Drugs Controller General of India (DCGI). It handles the import of all classes and the manufacturing of Class C and D devices.
• State Licensing Authority (SLA): Responsible for granting licenses to manufacture Class A and Class B devices.
• Notified Bodies: Third-party organizations registered with the CDSCO to audit the Quality Management Systems (QMS) of Class A and B manufacturing sites.

3. Key Regulatory Processes

• SUGAM Portal: All applications for import, manufacture, and clinical investigations are submitted online through the SUGAM portal.

• Product Licensing:

• Import: Application via Form MD-14 to receive a license in Form MD-15.

• Manufacture (Class C/D): Application via Form MD-7/8 for license in Form MD-9/10.

• Quality Management System (QMS): Compliance with the Fifth Schedule of MDR 2017 (aligned with ISO 13485) is mandatory for all manufacturers.

4. Post-Market Surveillance

The Materiovigilance Programme of India (MvPI) monitors and analyzes adverse events related to medical devices to protect patient health throughout the product's lifecycle.